Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1973 1
1975 2
1976 1
1977 1
1978 1
1979 2
1980 3
1981 3
1982 7
1983 3
1984 4
1985 7
1986 4
1987 3
1988 5
1989 6
1990 8
1991 7
1992 5
1993 7
1994 13
1995 14
1996 7
1997 11
1998 15
1999 17
2000 17
2001 22
2002 17
2003 30
2004 27
2005 28
2006 31
2007 31
2008 48
2009 37
2010 48
2011 53
2012 61
2013 42
2014 69
2015 88
2016 69
2017 64
2018 82
2019 76
2020 90
2021 84
2022 73
2023 58
2024 18

Text availability

Article attribute

Article type

Publication date

Search Results

1,237 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Breast Neoplasm, Unilateral"
Page 1
Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3-07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study.
Chua BH, Link EK, Kunkler IH, Whelan TJ, Westenberg AH, Gruber G, Bryant G, Ahern V, Purohit K, Graham PH, Akra M, McArdle O, O'Brien P, Harvey JA, Kirkove C, Maduro JH, Campbell ID, Delaney GP, Martin JD, Vu TTT, Muanza TM, Neal A, Olivotto IA; BIG 3–07/TROG 07.01 trial investigators. Chua BH, et al. Lancet. 2022 Aug 6;400(10350):431-440. doi: 10.1016/S0140-6736(22)01246-6. Lancet. 2022. PMID: 35934006 Clinical Trial.
BACKGROUND: Whole breast irradiation (WBI) after conservative surgery for ductal carcinoma in situ (DCIS) reduces local recurrence. ...METHODS: The study was an international, randomised, unmasked, phase 3 trial involving 136 participating centres of six clinical trials or …
BACKGROUND: Whole breast irradiation (WBI) after conservative surgery for ductal carcinoma in situ (DCIS) reduces local recurrence. . …
Bilateral breast cancers.
Narod SA. Narod SA. Nat Rev Clin Oncol. 2014 Mar;11(3):157-66. doi: 10.1038/nrclinonc.2014.3. Epub 2014 Feb 4. Nat Rev Clin Oncol. 2014. PMID: 24492834 Review.
An increasingly large proportion of women with unilateral breast cancer are treated with bilateral mastectomy. The rationale behind bilateral surgery is to prevent a second primary breast cancer and thereby to avoid the resultant therapy and eliminate the ris …
An increasingly large proportion of women with unilateral breast cancer are treated with bilateral mastectomy. The rationale b …
Contouring Guidelines for the Axillary Lymph Nodes for the Delivery of Radiation Therapy in Breast Cancer: Evaluation of the RTOG Breast Cancer Atlas.
Gentile MS, Usman AA, Neuschler EI, Sathiaseelan V, Hayes JP, Small W Jr. Gentile MS, et al. Int J Radiat Oncol Biol Phys. 2015 Oct 1;93(2):257-65. doi: 10.1016/j.ijrobp.2015.07.002. Epub 2015 Aug 6. Int J Radiat Oncol Biol Phys. 2015. PMID: 26383674
PURPOSE: The purpose of this study was to identify the axillary lymph nodes on pretreatment diagnostic computed tomography (CT) of the chest to determine their position relative to the anatomic axillary borders as defined by the Radiation Therapy Oncology Group (RTOG) breast …
PURPOSE: The purpose of this study was to identify the axillary lymph nodes on pretreatment diagnostic computed tomography (CT) of the chest …
Risk-Reducing Mastectomy and Breast Reconstruction: Indications and Evidence for Current Management Strategies.
Eisemann BS, Spiegel AJ. Eisemann BS, et al. Clin Plast Surg. 2018 Jan;45(1):129-136. doi: 10.1016/j.cps.2017.08.013. Epub 2017 Sep 29. Clin Plast Surg. 2018. PMID: 29080654 Review.
Breast cancer affects nearly every woman either personally or through a family member or friend. ...Contralateral risk-reduction mastectomy aims to decrease the incidence of contralateral breast cancer in women diagnosed with unilateral breast cancer. …
Breast cancer affects nearly every woman either personally or through a family member or friend. ...Contralateral risk-reduction mast …
EBCC-13 manifesto: Balancing pros and cons for contralateral prophylactic mastectomy.
Schmidt MK, Kelly JE, Brédart A, Cameron DA, de Boniface J, Easton DF, Offersen BV, Poulakaki F, Rubio IT, Sardanelli F, Schmutzler R, Spanic T, Weigelt B, Rutgers EJT. Schmidt MK, et al. Eur J Cancer. 2023 Mar;181:79-91. doi: 10.1016/j.ejca.2022.11.036. Epub 2022 Dec 13. Eur J Cancer. 2023. PMID: 36641897 Free PMC article. Review.
After a diagnosis of unilateral breast cancer, increasing numbers of patients are requesting contralateral prophylactic mastectomy (CPM), the surgical removal of the healthy breast after diagnosis of unilateral breast cancer. It is important for …
After a diagnosis of unilateral breast cancer, increasing numbers of patients are requesting contralateral prophylactic mastec …
Synchronous, bilateral mastectomy.
Staren ED, Robinson DA, Witt TR, Economou SG. Staren ED, et al. J Surg Oncol. 1995 Jun;59(2):75-9. doi: 10.1002/jso.2930590202. J Surg Oncol. 1995. PMID: 7776657 Clinical Trial.
Twenty-two patients had bilateral mastectomy because of bilateral positive biopsy. Twenty-nine patients with unilateral carcinoma on biopsy had bilateral mastectomy. Thirteen patients had bilateral mastectomy despite benign disease only on biopsy (10) or no biopsy (3). Ten …
Twenty-two patients had bilateral mastectomy because of bilateral positive biopsy. Twenty-nine patients with unilateral carcinoma on …
Metastatic nonhematopoietic neoplasms to the breast: a study of 238 cases.
Zhou P, Chang N, Abraham SC, Albarracin CT, Huo L, Chen H, Ding Q, Resetkova E, Middleton LP, Sahin AA, Bu H, Wu Y. Zhou P, et al. Hum Pathol. 2022 Jul;125:59-67. doi: 10.1016/j.humpath.2022.04.009. Epub 2022 Apr 18. Hum Pathol. 2022. PMID: 35447141 Review.
The aim of this study was to review the clinicopathologic characteristics of metastatic nonhematopoietic malignancies to the breast, in order to identify salient features for practicing pathologists that are useful in distinguishing metastatic lesions from primary breas …
The aim of this study was to review the clinicopathologic characteristics of metastatic nonhematopoietic malignancies to the breast, …
Bilateral Mastectomy in Women With Unilateral Breast Cancer: A Review.
Lim DW, Metcalfe KA, Narod SA. Lim DW, et al. JAMA Surg. 2021 Jun 1;156(6):569-576. doi: 10.1001/jamasurg.2020.6664. JAMA Surg. 2021. PMID: 33566074 Review.
IMPORTANCE: Rates of bilateral mastectomy continue to increase in average-risk women with unilateral in situ and invasive breast cancer. Contralateral prophylactic mastectomy rates increased from 5% to 12% of all operations for breast cancer in the US from 20 …
IMPORTANCE: Rates of bilateral mastectomy continue to increase in average-risk women with unilateral in situ and invasive breast …
The apical cap.
McLoud TC, Isler RJ, Novelline RA, Putman CE, Simeone J, Stark P. McLoud TC, et al. AJR Am J Roentgenol. 1981 Aug;137(2):299-306. doi: 10.2214/ajr.137.2.299. AJR Am J Roentgenol. 1981. PMID: 6789637
Apical caps, either unilateral or bilateral, are a common feature of advancing age and are usually the result of subpleural scarring unassociated with other diseases. Pancoast (superior sulcus) tumors are a well recognized cause of unilateral asymmetric apical densi …
Apical caps, either unilateral or bilateral, are a common feature of advancing age and are usually the result of subpleural scarring …
Breast cancer treatment in mutation carriers: surgical treatment.
Biglia N, D'Alonzo M, Sgro LG, Tomasi Cont N, Bounous V, Robba E. Biglia N, et al. Minerva Ginecol. 2016 Oct;68(5):548-56. Epub 2016 Jan 28. Minerva Ginecol. 2016. PMID: 26822896 Free article. Review.
The surgical option which should be reserved for patients with BRCA1/2 mutation and breast cancer diagnosis is still debated. Several aspects should be considered before the surgical decision-making: the risk of ipsilateral breast recurrence (IBR), the risk of contr …
The surgical option which should be reserved for patients with BRCA1/2 mutation and breast cancer diagnosis is still debated. Several …
1,237 results